Science Market Update
One of the ways to measure how well a program or department at a university is doing is to look at their graduate programs. To be able to offer the PhD in a specialized area, you need qualified faculty willing and able to take on teaching and mentoring responsibilities; a strong reputation for excellence in the area; research opportunities (and RA funding) for those doctoral students; and equipment and laboratory facilities, to name just a few factors. So when you see an institution win a major grant to launch a PhD program, you know that's a hot area for research and facilities expansion as well.
|(Courtesy of http://www.abc.net.au/)|
Every week we see commericals on television asking if we have Mesothelioma. By the number of commercials alone you would be right in thinking Mesothelioma is a serious problem. That's why it's particularly important that a major cancer research institution, the University of Hawaii Cancer Center, recently received a $600,000 grant from the Jimmy Valvano Foundation for Cancer Research. The grant was awarded to the research lab of pathologist Michele Carbone to study HGMB1: A Biomarker for Mineral Exposure and Detection of Malignant Mesothelioma. According to Dr. Carbone:
Funding makes laboratory research possible, which makes discovery possible, which leads to advancing knowledge and treatment options. But the primary job of a top scientist and lab director should not be to write grant proposals at the expense of time spent actually doing research. With that insight in mind, the University of California San Francisco put a system in place 5 years ago called the Resource Allocation Program (RAP). The function of the RAP is to streamline the intramural funding process so that faculty only have to fill out one application for many grants, and then only twice a year on set dates. A recent review of the program shows it to be a success, with a 66% increase in overall applications submitted and approximately a 20% increase in funding awarded in the past year alone.
Tags: CA, University of California San Francisco, biomedical research, 2012 Research Funding, Southwest, California, 2012, San Francisco, Funding, Biotechnology Vendor Showcase, UCSF, Biomedical Research Funding, Mission Bay Campus, UCSF Mission Bay
Washington University in St Louis (WUSTL) has just received a $2M research grant that will go towards combating a disorder which afflicts, often fatally, nearly 5.8 million Americans each year: heart failure. Heart failure is one of the leading causes of death in the US and although many promising drugs have been introduced over the years, we have yet to find a definitive treatment for the variety of cases that doctors encounter. This $2M NIH award wil go to a team of WUSTL scientists for basic research that will contribute to our understanding of heart disease and ideally lead to more effective treatment. The end goal of this research project is the design and construction of artificial tissue models of the heart, which will allow scientists to more quickly and efficiently test new drugs.
Tags: Bioscience research, Midwest, biomedical sciences, biomedical research, Bioresearch, Washington University, Missouri, WUSTL, heart disease, 2012, Biochemistry, BioResearch Product Faire Event, Research, NIH, MO, St Louis, BRPF, basic research funding
The University of Hawaii Cancer Center has successfully renewed its National Cancer Institute (NCI) designation and is on schedule to open its new world-class cancer research and treatment facility near the John A. Burns School of Medicine (JABSOM) in the Kaka’ako district of Honolulu early next year. The Hawaiian biomedical research center is the only NCI-level facility in the Pacific Islands and one of only 66 NCI research organizations in the U.S. The island state may be a tropical paradise and vacation destination in the popular imagination, but there's no doubt that its capital city is also becoming a serious biomedical research magnet as well.
Tags: biomedical research, Bioresearch, Biomedical expansion, University of Hawaii, cancer research, New research facilities, new science wet labs, Southwest, 2012, Hawaii, Cancer, Front Line event, Honolulu, HI, new construction, Cancer Center
The University of Colorado already has a terrific medical program at its Anschutz Medical Campus. This April we talked about their groundbreaking efforts against multiple sclerosis. Now, Anschutz Medical is waging war on one of America's greatest enemies: obesity.
Biomedical science researchers have worked tirelessly at the University of California, Riverside since the discovery of a crucial link involving mice, humans, and Alzheimer's disease. Back in 2006, UCR researchers, in a collaborative effort with the University of South Florida, discovered an interesting connection between the immune system and Alzheimer's disease while experimenting on lab mice. Professor Douglas Ethell, the assistant professor of Biomedical Sciences at UCR, along with the USF's own Professor Gary Arendash of the Johnnie B. Byrd Institute, was instrumental in this find.
The first construction of an image by Nuclear Magnetic Resonance (NMRI) by Dr. Paul Lauterbur took place at the University at Stony Brook thirty years ago, and the Stony Brook Chemistry professor went on to win the 2003 Nobel Prize for his work. So it's fitting that another breakthrough in MRI technology is also taking place at the Long Island research university, this time by biomedical engineer Balaji Sitharaman, right, and his team, who have developed a potentially safer and more cost effective MRI contrast agent for improved disease diagnosis and detection. The agent is graphene-based rather than gadolinium-based, and the success of the advanced agent is documented in a recent PLoS ONE article.
Tags: biomedical sciences, biomedical research, Northeast, New York, Stony Brook University, venture development in life sciences, BioResearch Product Faire Event, Biomedical Research Funding, scientist solutions, life science products, science solution
University of Cincinnati College of Medicine molecular geneticist Daniel Hassett (right) has made a name for himself as a determined researcher in the fight against cystic fibrosis (CF). He is also on the front line of bioscience research into creating "superbugs" that eat waste and generate energy, improving dramatically on the efficiency of traditional waste water treatment systems. In a radio interview on WVXU Cincinnati's Focus on Technology, commentator Ann Thompson describes the problem: the largest user of energy is wastewater treatment; the second largest user of water is energy production. If you can find a way to both clean water and generate electricity, you're in business.
Tags: Bioscience research, Midwest, Ohio, biomedical research, University of Cincinnati, genetic engineering, molecular ecology research, BioResearch Product Faire Event, Cincinnati, BRPF, research scientist